High Expression of MRPL23 Is Associated with Poor Survival in Clear-Cell Renal Cell Carcinoma
MRPL23 protein expression is a potential independent prognostic biomarker in ccRCC, emphasizing its utility in predicting patient outcomes and potentially guiding therapeutic decisions. These findings highlight the importance of further research into the role of MRPL23 in ccRCC pathogenesis and its potential as a therapeutic target.
Authors
- Dominika Łukasik
- Dariusz Grzanka (ORCID: https://orcid.org/0000-0002-0416-7583)
- Justyna Durślewicz (ORCID: https://orcid.org/0000-0001-7301-5324)
- Jędrzej Borowczak (ORCID: https://orcid.org/0000-0001-9873-3285)
- Edyta Podemska
Institutions
- Nicolaus Copernicus University (PL)
- Collegium Medicum in Bydgoszcz (PL)
Publication Details
- Journal
- Cancers
- Published
- 2024-11-21
- DOI
- https://doi.org/10.3390/cancers16233909
- Citations
- 2
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.84